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Abstract
Introduction: Malawi introduced a new strategy to improve the effectiveness of prevention of mother-to-child HIV transmission
(PMTCT), the Option B strategy.We aimed to (i) describe how Option B is provided in health facilities in the South East Zone
in Malawi, identifying the diverse approaches to service organization (the ‘‘model of care’’) and (ii) explore associations between
the ‘‘model of care’’ and health facilitylevel uptake and retention rates for pregnant women identified as HIV-positive at
antenatal (ANC) clinics.
Methods: A health facility survey was conducted in all facilities providing PMTCT/antiretroviral therapy (ART) services in six of
Malawi’s 28 districts to describe and compare Option B service delivery models. Associations of identified models with
program performance were explored using facility cohort reports.
Results: Among 141 health facilities, four ‘‘models of care’’ were identified: A) facilities where newly identified HIV-positive
women are initiated and followed on ART at the ANC clinic until delivery; B) facilities where newly identified HIV-positive women
receive only the first dose of ART at the ANC clinic, and are referred to the ART clinic for follow-up; C) facilities where newly
identified HIV-positive women are referred from ANC to the ART clinic for initiation and follow-up of ART; and D) facilities serving
as ART referral sites (not providing ANC). The proportion of women tested for HIV during ANC was highest in facilities applying
Model A and lowest in facilities applying Model B. The highest retention rates were reported in Model C and D facilities and
lowest in Model B facilities. In multivariable analyses, health facility factors independently associated with uptake of HIV testing
and counselling (HTC) in ANC were number of women per HTC counsellor, HIV test kit availability, and the ‘‘model of care’’
applied; factors independently associated with ART retention were district location, patient volume and the ‘‘model of care’’
applied.
Conclusions: A large variety exists in the way health facilities have integrated PMTCT Option B care into routine service
delivery. This study showed that the ‘‘model of care’’ chosen is associated with uptake of HIV testing in ANC and retention in care
on ART. Further patient-level research is needed to guide policy recommendations.
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Introduction
In 2011, Malawi introduced a new strategy to improve the
effectiveness of its prevention of mother-to-child HIV trans-
mission (PMTCT) program by providing a standardized combina-
tion antiretroviral therapy (ART) regimen to all HIV-positive
pregnant and breastfeeding women, irrespective of their
CD4 count or clinical stage of HIV infection, and that ART
be continued lifelong. This was an extension of an existing
WHO recommendation for PMTCT (Option B) and Malawi’s
strategy was therefore dubbed Option B. This public health
approach for PMTCT has since been adopted by several other
countries in the region and was included in the updated
WHO guidelines in 2013 [1]. The Option B strategy has
also received criticism citing lack of a firm evidence base,
including unstudied effects of long-term ART in otherwise
healthy women and infants, and potential for increased drug
resistance with poor adherence [2,3].
Upon initiation of the new strategy, practical issues about
how to organize HIV care and ART provision for women in
antenatal care (ANC) arose across the spectrum of often
poorly staffed health facilities in Malawi. Despite these
challenges, initial reports demonstrated that the Option
B strategy has resulted in large increases in the number
of pregnant women accessing PMTCT [4]. However, concern
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has been raised about the level of attrition of women from
care and it has been noted that large variations exist in rates
of retention between health facilities [5].
Clearly, more information is needed about the factors that
determine retention and attrition in pregnant women who
start ART under the Option B strategy.
From July 2011 onwards, health facilities in Malawi were
tasked with integrating Option B into the routine service
delivery and as this was uncharted territory, the Malawi
Ministry of Health did not provide specific guidelines for
how this should be done. Different approaches had to be
considered which would account for the location of ART
initiation (at the ANC or ART clinic), the timing of ART initia-
tion after a positive HIV test result, the timing and type of
adherence counselling for ART initiation, the location of
follow-up after delivery and/or breastfeeding, and the type
of support women receive. There was no evidence about
how these different approaches would affect acceptability,
uptake, adherence and retention in care over the course of
pregnancy, during lactation, and post-lactation.
The aim of this study was to describe how the PMTCT/
Option B services are being delivered to pregnant women
in health facilities in the South-East Zone in Malawi, iden-
tifying the diversity in approaches to service organization (the
‘‘model of care’’). We also aimed to explore associations
between the ‘‘model of care’’ and national program indica-
tors at health facility level, in particular uptake of HIV testing
in ANC, and uptake of and retention in care on ART.
Methods
Malawi National ART/PMTCT program
The scale-up of free ART started in 2004 using standard ART
regimens and relying mainly on clinical monitoring for toxicity
and treatment failure. The program has a monitoring and
evaluation framework of high quality [6]. PMTCT was started
in 2002, and evolved from the use of single dose nevirapine
(sdNVP) for mother and infant, to combination prophylaxis
with twice daily zidovudine (AZT) for the mother during
pregnancy with the addition of sdNVP during labour, a one
week AZT-lamivudine (3TC) tail, and onefour week prophy-
laxis with AZT-syrup for the infant) [7] implemented since
2007, but only in the larger health facilities in the country. In
2011, the Option B strategy was initiated using a single-
tablet fixed dose combination of tenofovir, lamivudine and
efavirenz [8]. The sdNVP regimen and the AZT combination
prophylaxis were phased out by April 2012. By the end of
June 2013, there were 588 sites enrolling women under
PMTCT Option B [9].
South East Zone of Malawi
Malawi is divided into 28 districts and organized into five
health zones. The South East Zone includes six districts and
has approximately 3.5 million inhabitants (23% of the total
population of 14.8 million in 2012). There are around 154,000
pregnancies in the South East Zone per annum and 22,500
(14.6%) of these are among HIV-positive women [10].
By June 2013, the South East Zone counted 153 facilities
with integrated HIV care services, of which 94% provided
PMTCT Option B [9]. The Canadian non-governmental
organization Dignitas International has been operating in
partnership with the Malawi Ministry of Health since
2004, initially in Zomba District, and expanding throughout
the South East Zone from 2010 to support the delivery
of HIV-related services through training, mentorship and
supervision.
Facility-level data: study methodology, data collection,
definitions and statistical analysis
A survey was conducted in all health facilities providing
PMTCT/ART services in the South East Zone to describe
PMTCT/Option B service delivery models. Associations
were explored between these models and the uptake of
HIV testing and counselling (HTC) and ART among pregnant
women, as well as the six- and 12-month treatment out-
comes among women registered as having started ART under
Option B.
Facility survey
Data on the organization of Option B service delivery were
collected between February and June 2013, using a struc-
tured questionnaire administered to the health facility officer
in-charge. It included questions regarding staff involved in
PMTCT/ART provision, availability of ANC/ART services (of-
fered all weekdays or not), location where newly HIV-positive
women are initiated on ART (at ANC or ART clinic), timing and
type of adherence counselling for ART initiation (same day as
ART initiation, during next visit after ART initiation or both,
and in group or individual sessions) and the timing of transfer
to ART or motherinfant-pair (MIP) clinic. Facilities that
indicated that their organizational arrangement had changed
within the past six months were excluded from the analysis.
Facility-level cohort data
Routinely collected health facility cohort reports that are
validated quarterly were used to ascertain uptake of HTC and
ART initiation for pregnant women with newly identified HIV
infections in ANC between July 2012 and June 2013. These
included information about HIV test kit stock outs. Routinely
collected cohort survival outcome data were used to evaluate
outcomes for women registered as having started ART under
Option B. Cohort reports of women who started between
July and December 2012 were used for six-month outcomes;
and reports of those who started between January and June
2012 were used for 12-month outcomes. To explore changes
over calendar time, six-month outcomes were also ascer-
tained for women who started between January and June
2012.
Retention was defined as the number of women retained
on ART (by six or 12 months) divided by the number of
women in the cohort minus the number of women who
transferred out during the observation period. As per the
national guideline, women on ART were counted as ‘‘de-
faulted’’ if they were expected to have run out of ARVs for
two or more months (based on the number of tablets given
at the last visit) and were not known to have transferred out,
stopped or died [11].
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Statistical analysis
Data analyses were conducted using IBM SPSS Statistics 20
(IBM, Armonk, NY, USA). Health facility characteristics were
described with proportions and 95% confidence intervals
[CI] or medians with interquartile ranges [IQR]. Four PMTCT
Option B service delivery models were identified through
the descriptive analysis of the health facility survey and were
used as categories for further analysis. Comparisons between
groups were made using the Chi-square test, nonparametric
independent sample median tests and analysis of variance.
To explore associations between service organization and
uptake of HTC during ANC at facility level, binary logistic
regression models were fitted with the proportion of women
with HIV status ascertained 85% (above the national target
for 20122013[12]) as the outcome variable.
To explore associations between service organization and
retention rates at health facility level, multinomial logistic reg-
ression models were fitted with ‘‘six-month retention rate’’ at
health facility level as the outcome variable. In the absence
of a widely accepted definition of a good/acceptable/bad
six-month retention rate, we used the IQR as the reference
category in these analyses, with low retention defined as
below the IQR and high retention defined as above the IQR.
Continuous predictor variables were similarly categorized,
except that the category below the IQR was used as the
reference category, and the other categories were entered in
the model in order of increased retention.
Crude odds ratios (OR) and adjusted odds ratios (aORs)
with 95% CI’s were calculated for each model and were
controlled for all the variables in the model, namely district,
facility type, PMTCT/ART services availability, number of
women registered or in the Option B cohort, client pro-
vider ratios and model of Option B provision as defined
in results section. In addition, quarterly HIV test kit stock
outs were included in the model exploring associations with
uptake of HTC, and timing of adherence counselling and
availability of ART/MIP clinics for follow-up were included in
the model exploring associations with retention rates. A
significance level of 0.05 was set for all statistical testing.
Ethical approval
Ethical approval was granted by the National Health Sciences
Research Committee, Malawi (#1084) and the Ethics Ad-
visory Group of the International Union Against Tuberculosis
and Lung Disease, Paris, France (#71/12).
Results
Study sites
Of 153 health facilities in the South East Zone providing
PMTCT/ART services at the time of the survey, 141 were
included in the study. Not included were Zomba Central
Hospital, one of the four central referral hospitals in the
country, 10 facilities that had only recently started providing
PMTCT Option B services, and one health centre that was
overlooked by the study team.
Table 1 gives an overview of the health facility characteristics.
Table 1. Health facilities, number of staff involved in PMTCT/ART provision, and number of women newly registered for ANC and
ART initiation during ante-natal care
Expressed in median (IQR) or Totals
District hospital
(n4)
Community
hospitals (n8)
Health centres
(n120)
Private clinics
(n9)
Total
(n141)
Medical assistants 5 (125) 2 (24) 1 (12) 0 (00) 198
Nurses/midwives 40 (2372) 19 (1428) 2 (13) 3 (23) 712
Clinical officers 5 (29) 3 (15) 0 (00) 1 (12) 82
Medical doctors 2 (23) 0 (01) 0 (00) 0 (01) 20
HTC counsellors 14 (624) 8 (410) 4 (35) 2 (23) 614
ART initiation counsellors 5 (417) 3 (17) 1 (12) 0 (00) 262
Expert patients 2 (13) 2 (02) 1 (02) 0 (00) 188
ART clerks 4 (28) 2 (12) 2 (12) 1 (01) 280
Total number of staff 90 (60139) 39 (3146) 12 (915) 9 (811) 2356
Average number of women newly registered for
ANC per quarter (based on quarterly data Jul
2012Jun 2013)a
1025 (8391318) 377 (282538) 265 (146373) 116 (7225) 41,203
Average number of women newly tested positive
at ANC per quarter (based on quarterly data
Jul 2012Jun 2013)a
79 (6896) 21 (1231) 11 (619) 6 (116) 2111
Number of women registered as having started
ART (Option B) between JanJun 2012b
194 (90298) 134 (59151) 49 (2789) 10 (320) 8864
Number of women registered as having started
ART (Option B) between JulDec 2012b
184 (74300) 105 (79136) 50 (3371) 14 (422) 9343
Note: ANCantenatal care; ARTantiretroviral therapy.
aANC not provided in one district hospital, three health centres and five private clinics; bART not provided in one private clinic.
van Lettow M et al. Journal of the International AIDS Society 2014, 17:18994
http://www.jiasociety.org/index.php/jias/article/view/18994 | http://dx.doi.org/10.7448/IAS.17.1.18994
3
Identified models of care
The organization of Option B service delivery in the dif-
ferent facilities is presented in Figure 1.
Model A: Newly identified HIV-positive women are initiated
and followed on ART at the ANC clinic until delivery.
In 26 out of the 75 facilities applying Model A, ANC/ART
services were offered on all weekdays and in 49 facilities on
certain weekdays only. In the majority of facilities, adherence
counselling was reported to be provided on the day of ART
initiation only. Thirty-seven of the 75 facilities reported pro-
viding both individual and group counselling, 31 facilities
provided individual counselling only. Seven of the 12 facilities
that reported providing counselling during the next visit after
ART initiation only, did so in group sessions only. All facilities
transferred motherinfant pairs to the MIP or ART clinics at
the six-week postnatal visit.
Model B: Newly identified HIV-positive women receive only
the first dose of ART at the ANC clinic and are then referred to
the ART clinic for follow-up.
In 17 of the 38 facilities applying Model B, ANC/ART services
were offered on all weekdays and in 21 facilities on certain
weekdays only. In the majority of facilities, adherence coun-
selling was reported to be provided on the day of ART initia-
tion only, through individual counselling only (11 facilities),
group counselling only (two facilities), or both (seven
facilities).
Model C: Newly identified HIV-positive women are referred
from the ANC clinic to the ART clinic in the same facility for
initiation and follow-up of ART.
Of the 18 facilities applying Model C, nine do so on a daily
basis and nine less than daily, but in all facilities ART clinics
are run on the same days as ANC clinics. Adherence coun-
selling is expected to take place during ART initiation in the
ART clinic.
Model D: Facilities that serve as ART referral sites and do not
provide ANC.
Pregnant and breastfeeding women may start and/or are
followed on ART after referral from an ANC or Maternity
Clinic in another site. These facilities reported providing
adherence counselling at the time of ART initiation, one
through both individual and group counselling, and eight
facilities through individual counselling only.
Performance of health facility by model of care
In Table 2, health facility performance is shown in relation to
the organization of the Option B service delivery model.
There were no significant differences across the models
in median number of women registered for ANC, median
number of known HIV-positive or newly HIV test-positive
pregnant women, and the proportion of known HIV-positive
women already on ART per health facility per quarter.
A significant difference was found in the proportion of
women who were tested for HIV during ANC, with the lowest
Model D 
Facilities not 
providing ANC, but 
serving as ART 
referral sites:
(n=9) 
Facilities providing both ANC and ART services 
(n=131)
Model B
Facilities where women 
receive only first dose of ART 
at ANC, and are referred to 
the ART clinic for follow-up:
(n=38)
Model A
Facilities where women
are initiated and 
followed on ART at ANC 
until birth 
(n=75)
Model C 
Facilities where women 
are referred from ANC to 
the ART clinic for initiation 
and follow-up:
(n=18) 
At day of ART initiation
or transfer in       (n=9)
Same day at ANC (n=29)
Next visit at ART (n=2)
Both at ANC and ART (n=7)
Timing and place of Adherence Counseling for ART initiation
Same day at ANC (n=47)
Next visit at ANC  (n=12)
Both at ANC         (n=16) 
At day of ART initiation at 
ART clinic 
(n=18)
Timing of Mother or Mother-Infant pair (MIP) transfer to ART
No transfer      (n=9)No transfer (n=16)
at 6 weeks postnatal visit:
to MIP clinic (n=2)
After receiving first dose of 
ART at ANC, 
to ART clinic               (n=38)
Facility providing ANC, but no ART services (referring to a different site for ART initiation) not included
at 6 weeks postnatal visit:
to ART clinic      (n=24)
to MIP clinic      (n=51)
Figure 1. PMTCT service delivery models in health facilities in the South East Zone in Malawi.
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Table 2. Health Facility Performance by PMTCT service delivery model
Model A
(n73)a
Model B
(n36)a
Model C
(n18)
Model D
(n9) p
Facility type District hospitals 2 1  1
Community hospitals 5  3 
Health centres 64 35 14 3
Private clinics 2  1 5
ANC indicators (based on
quarterly data July
2012Jun 2013)
Average number of women newly registered for ANC per quarter, median (IQR) 252 (141401) 316 (205445) 224 (128301) 0.07
Average number of women known HIV-positive (previously tested positive), median (IQR) 5 (39) 4 (313) 4 (39) 0.79
Average number of women newly tested positive, median (IQR) 11 (620) 12 (722) 10 (417) 0.42
% of known HIV-positive women already on ART (started before ANC) (95% CI) 84 (7989) 81 (7587) 85 (7694) 0.71
% of HIV-positive women (not already on ART) started ART during ANC (95% CI)b 82 (7687) 81 (7489) 80 (6891) 0.96
% women not tested for HIV during ANC (95% CI) 18 (1522) 32 (2639) 30 (2040) 0.001
Survival and retention
6 month outcomes Number of women in cohort, median (IQR) 52 (3372) 55 (35115) 45 (2367) 26 (1537) 0.13
Registered JulDec 2012 % of women transferred out (95% CI) 8 (511) 5 (36) 6 (113) 10 (219) 0.49
Of those not transferred out % retained on ART (95% CI) 80 (7784) 79 (7482) 89 (8495) 92 (8399) 0.008
% not retained (95% CI)
Defaulted 18 (1422) 20 (1625) 10 (515) 7 (117) 0.02
Stopped 0.4 (00.1) 0.01 (00.1) 0.01 (00.1)  0.62
Died 1 (02) 0.01 (01) 1 (01) 0.02 (01) 0.58
Survival and retention
12 month outcomes Number of women in cohort, median (IQR) 52 (2886) 51 (31124) 28 (1774) 21 (1076) 0.87
Registered JanJun 2012 % of women transferred out (95% CI) 8 (511) 7 (49) 4 (26) 10 (120) 0.42
Of those not transferred out % retained on ART (95% CI) 80 (7783) 77 (7382) 87 (8392) 94 (8899) 0.002
% not retained (95% CI)
Defaulted 18 (1522) 22 (1725) 12 (816) 6 (111) 0.006
Stopped 1 (02) 0.01 (00.1) 1 (01)  0.55
Died 1 (02) 0.01 (01) 1 (01) 0.3 (0.11) 0.70
Client to staff ratio Number of women newly registered for ANC per Clinical Staffc Member per month, median (IQR) 23 (1033) 34 (2443) 11 (526)  0.001
Number of women newly registered for ANC per HTC Counsellor per month, median (IQR) 19 (1023) 36 (1947) 15 (1027)  0.02
Number of women in six month cohort per
Clinical Staffc Member, median (IQR) 12 (620) 21 (1129) 9 (313) 6 (310) 0.02
Note: Model A: Facilities where women are initiated and followed on ART at ANC until delivery; Model B: Facilities where women receive only first dose of ART at ANC, and are referred to the ART clinic for
follow-up; Model C: Facilities where women are referred from ANC to the ART clinic for initiation and follow-up of ART; Model D: Facilities serving as ART referral sites (not providing ANC).
aFacilities (Model A: 2, Model B: 2) excluded as the organization had recently changed from referring women to the ART clinic, to initiating them on ART at the ANC clinic, following MOH recommendations;
bstarted ART during antenatal period; before or after 27 weeks gestation combined; cMedical Doctors, Clinical officers, Nurses, Midwives, Medical Assistants.
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5
proportion in facilities using Model B and the highest in
facilities using Model A.
The median number of women per health facility in the
most recent six month cohort, i.e. women who started ART
(Option B) between July and December 2012, was 51 (IQR
3182) with no significant difference between the models.
In this cohort, the proportion of women who transferred to
another health facility was not significantly different between
the models. However, significant differences in retention on
ART and defaulting were observed across the models; the
highest proportion of defaulting occurred in facilities using
Model B and the lowest in Model D facilities.
Observations were similar in the earlier cohort registered
between January and June 2012. Across all health facilities, at
six months 6% (95% CI 58) had transferred out, 15% (95% CI
1217) had defaulted from care and 84% (95% CI 8188)
were retained on ART. At 12 months, 7% (95% CI 69) had
transferred out, 17% (95% CI 1520) had defaulted and 81%
(7984) were retained on ART. At 6 and 12 months, sig-
nificant differences in retention on ART and defaulting were
observed between the models, the highest proportion of
defaulting occurred in facilities using Model B and the lowest
in Model D facilities.
Client to staff ratios were significantly different across
the models, the number of women per clinical staff and HTC
counsellors were highest in Model B facilities and lowest in
Model C and D facilities.
Characteristics of health facilities and associations with
uptake of HTC at ANC
Table 3 describes the results of univariable and multivariable
binary logistic regression analysis, in which we explored
associations between characteristics of health facilities and
Table 3. Characteristics of health facilities and association with 85% of women with HIV status ascertained during ANC at facility
level
N
% HIV Status
ascertained at ANC
med (IQR)
Crude OR
(95% CI) p
Multivariable OR
(95% CI)a p
District District 1 17 85 (7295)  
District 2 37 76 (4683) 0.2 (0.050.7) 0.01
District 3 14 79 (7384) 0.3 (0.061.5) 0.1
District 4 21 82 (7490) 1.0 (0.33.7) 0.9
District 5 11 75 (6087) 0.6 (0.13.0) 0.6
District 6 32 83 (7193) 0.7 (0.22.5) 0.7
Facility type District hospitals 3 90 (8392)  
Community hospitals 8 82 (6791) 0.3 (0.024.9) 0.4
Health centres 117 78 (6587) 0.2 (0.022.5) 0.2
Private clinics 4 88 (6893) 0.5 (0.0211) 0.6
Number of women registered in
ANC per quarter
B147 33 84 (7791)  
IQR 147400 66 78 (6287) 0.5 (0.21.2) 0.1
400 33 75 (6085) 0.5 (0.21.2) 0.1
Number of women registered for
ANC per clinical staffb
B12 33 84 (7792) 5.0 (1.616) 0.007
IQR 1237 65 80 (6689) 2.8 (1.08.4) 0.06
37 34 72 (5582)  
Number of women registered for
ANC per HTC counsellor
B13 33 86 (7694) 34 (4200) 0.001 44 (4500) 0.003
IQR 1338 66 81 (7089) 17 (2131) 0.007 15 (2132) 0.01
38 34 71 (4479)    
Number out of 4 quarterly
observations ‘‘out of stock’’
of HIV test kits
0 30 82 (7890) 5.2 (1.027) 0.05 3.1 (0.520) 0.2
1 41 84 (7491) 7.7 (1.638) 0.01 7.2 (1.350) 0.03
2 40 77 (6386) 3.4 (0.717) 0.1 2.2 (0.414) 0.4
3 or 4 20 74 (6282)    
Model of Option B service
provisionc
Model A 73 84 (7592) 4.6 (1.712.4) 0.002 3.4 (1.0112) 0.05
Model B 36 74 (5582)    
Model C 18 76 (6080) 0.6 (0.13.2) 0.54 0.3 (0.052.8) 0.3
aControlled for all other variables shown in this table. In the multivariable analysis, variables with significant associations are shown only;
bMedical Doctors, Clinical officers, Nurses, Midwives, Medical Assistants.
cModel A: Facilities where women are initiated and followed on ART at ANC until delivery; Model B: Facilities where women receive only first
dose of ART at ANC, and are referred to the ART clinic for follow-up; Model C: Facilities where women are referred from ANC to the ART clinic for
initiation and follow-up of ART.
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uptake of HTC among pregnant women newly registered for
ANC between July 2012 and June 2013.
In multivariable analysis, health facility factors indepen-
dently associated with high uptake of HTC were the number
of women registered per HTC counsellor, the number of
observations ‘‘out of stock’’ of HIV test kits, and the ‘‘model
of care’’ applied.
In comparison to facilities with more than 38 women per
HTC counsellor per month (above IQR); facilities with 1338
(IQR) or less than 13 (below IQR) women per HTC counsellor
per month were 15 and 44 times more likely to have high
uptake of HTC in ANC [aOR 15(2132) and aOR 44(4500)].
Facilities with at most one quarterly observation ‘‘out of
stock’’ of HIV test kits were seven times more likely to have
high uptake of HTC in ANC than facilities with three or four
observations ‘‘out of stock’’ [aOR 7.2 (1.350)].
In comparison with Model B, facilities using Model A were
three times more likely to have higher uptake of HTC in ANC
[aOR 3.4 (1.0112)].
Characteristics of health facilities and associations with
retention on ART (option B)
Table 4 describes the results of multinomial univariable and
multivariable logistic regression analyses, in which we
explored associations between characteristics of health
facilities and six-month retention rates for the cohorts of
women registered between July and December 2012.
In multivariable analysis, health facility factors indepen-
dently associated with low or high six-month retention were
district location, number of women in the cohort, and the
‘‘model of care’’ applied.
Health facilities in districts 4 and 6 were less likely to have
lower retention rates than health facilities in other districts,
independent of other health facility characteristics.
Facilities with less than 31 women (below IQR) in the six-
month cohort were five times more likely to have high
retention rates than facilities with more than 82 women
(above IQR) in the cohort [aOR 5.1 (1.222)].
In comparison with Model B, facilities using Model C were
five times more likely to have higher retention rates [aOR 5.4
(1.228)].
Discussion
In Malawi, the Option B strategy has been scaled up with
major increases in HIV-positive women starting ART during
pregnancy [4,9]. Our study shows that a large variation exists
in the way health facilities in the South East Zone of Malawi
have integrated PMTCT Option B care into their routine
service delivery. We identified four models of PMTCT care
provision and found that these ‘‘models of care’’ were
associated with uptake of HTC at ANC clinics and retention
in care on ART. We observed that worse program indicators
were found in Model B facilities in which women receive the
first dose of ART at the ANC clinic and are then transferred to
the ART clinic for ART follow-up. In these facilities, 32% of
women did not receive an HIV test at ANC and 20% of
women who started ART under Option B had defaulted six
months after initiation.
Following current Ministry of Health recommendations,
several health facilities have recently changed their practice
from referring women to the ART clinic to initiating them
on ART at the ANC clinic. However, our findings suggest
that such a change may only be beneficial if identified HIV-
positive pregnant women are initiated and followed on ART
at the ANC clinic until delivery. We found that health facilities
that opted for Model B also had highest clientstaff ratios,
which may have driven the choice of approach. In such
situations, referral to an ART clinic for initiation and follow-up
of ART may seem more efficient.
Our study stresses the need for further patient-level re-
search to ascertain which models of care are most successful
in having women accept initiation and lifelong continuation
of ART. It has been reported that pregnant women who
initiated ART on the day of diagnosis were almost twice as
likely not to return for follow-up after the initial visit [5]. In
such circumstances, women may be insufficiently able to
comprehend and accept the full consequences of a positive
HIV test and the need to start lifelong ART all at once.
Despite the apparent availability of HTC in ANC settings,
many pregnant women still do not get tested, and thereby
miss a potential opportunity to prevent vertical transmission
to their infants and care for their own health. A recent study
that we conducted in Malawi reported that some mothers
chose not to get tested for fear of stigmatization and that the
main system-related barriers to getting tested during preg-
nancy were lack of available resources and women not being
offered a test [13]. Facilities where HIV-positive women were
initiated and followed on ART at the ANC clinic (Model A)
had significantly lower proportions of untested women than
facilities where women were referred to the ART clinic or
were initiated on ART in ANC and then referred to the ART
clinic. It is possible that when ANC personnel are fully in-
volved in providing ART until delivery, there may be a greater
recognition of the importance of identifying women in need
of ART. We found that in some facilities ART adherence
counselling was first conducted at the first visit after ART
initiation. It is likely that in those facilities some women who
started ART had not made a fully informed choice to start
and adhere to treatment and were consequently more likely
to stop after their first dose of ART received in the ANC clinic.
In facilities where pregnant women are diagnosed with HIV at
ANC and then referred to the ART clinic for initiation, they
probably have more time for reflection, consider disclosure
of their status to their partner, and may therefore be better
prepared to start ART [1416]. Optimal timing and quality of
counselling and whether time between HIV diagnosis and
ART initiation affect retention on treatment are priorities for
further operational research.
We found no differences in treatment outcomes between
the earlier and most recent six-month cohorts, suggesting
that the effects of health facility variables are stable over
time and not the result of start-up problems in a new
situation. There was no notable loss in retention between six
and 12 months follow-up. This is consistent with findings
from a recent national study indicating that most losses
among newly started pregnant women were observed in the
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Table 4. Characteristics of health facilities and association with retention on ART (Option B ) at facility level
six-month
Crude OR (95% CI) Multivariable OR (95% CI)a
retention
reference category 72%92% reference category 72%92%
N med (IQR) B72% p 92% p B72% p 92% p
District District 1 17 71 (6778)       
District 2 40 79 (6490) 0.6 (0.22.2) 0.5 3.6 (0.434) 0.3 1.1 (0.25.0) 0.9 5.0 (0.467) 0.2
District 3 14 79 (7395) 0.2 (0.031.1) 0.06 4.3 (0.447) 0.2 0.3 (0.042.4) 0.3 5.7 (0.387) 0.2
District 4 21 86 (7890) 0.07 (0.10.4) 0.004 0.7 (0.059) 0.7 0.06 (0.010.41) 0.004 0.6 (0.049) 0.7
District 5 12 90 (8094) 0.1 (0.010.9) 0.04 3.5 (0.340) 0.3 0.2 (0.012.1) 0.2 5.7 (0.399) 0.2
District 6 31 91 (8598) 0.1 (0.020.6) 0.01 5.2 (0.545) 0.2 0.2 (0.030.9) 0.04 8.5 (0.799) 0.1
Facility type District hospitals 4 70 (6088)    
Community hospitals 8 80 (6586) 0.4 (0.026) 0.5 0.3 (0.018) 0.4
Health centres 115 84 (7292) 0.3 (0.023) 0.3 0.4 (0.037) 0.6
Private clinics 8 96 (9099)  1.7 (0.137) 0.7
ART/PMTCT services available and offered Certain weekdays 79 86 (7492) 0.6 (0.31.5) 0.3 1.1 (0.52.7) 0.8
Daily (all weekdays) 51 80 (6590)    
Number of women in B31 33 89 (8099) 1.3 (0.44.8) 0.6 4.1 (1.214) 0.03 1.5 (0.36.2) 0.6 5.1 (1.222) 0.03
six-month cohort IQR 3182 68 83 (7091) 2.1 (0.85.9) 0.1 2.3 (0.77.1) 0.2 2.7 (0.712) 0.2 2.2 (0.67.6) 0.2
(JulDec 2012) 82 34 81 (7591)        
Number of women in six month
cohort per clinical staffb
B7 35 82 (7199) 0.9 (0.33.0) 0.9 1.2 (0.43.9) 0.8
IQR 722 66 88 (7393) 0.8 (0.32.0) 0.6 1.1 (0.43.0) 0.9
22 35 81 (7591)    
Adherence Day of ART initiation 93 85 (7292)    
Counselling Next visit 14 87 (6695) 2.4 (0.610) 0.2 2.4 (0.69) 0.2
Both same day and next visit 24 86 (7691) 0.6 (0.21.9) 0.4 0.3 (0.11.3) 0.1
Availability of ART/MIP clinic for follow-up MIP clinic 29 78 (6789)    
ART clinic 106 86 (7593) 0.5 (0.21.2) 0.1 1.8 (0.56) 0.4
Model of Option B Model A 73 83 (7091) 1.0 (0.42.5) 0.9 1.7 (0.55.3) 0.4 0.9 (0.33.4) 0.9 3.0 (0.712) 0.1
service provisionc Model B 36 80 (7087)        
Model C 18 91 (8296) 0.5 (0.093) 0.5 4.6 (1.219) 0.04 0.4 (0.053.4) 0.4 5.4 (1.228) 0.04
Model D 9 95 (9099) 0.9 (0.0711) 0.9 8.0 (1.157) 0.04 0.9 (0.0616) 0.9 9.1 (0.984) 0.06
aControlled for all other variables shown in this table. In the multivariable analysis, variables with significant associations are shown only.
bMedical Doctors, Clinical officers, Nurses, Midwives, Medical Assistants.
cModel A: Facilities where women are initiated and followed on ART at ANC until delivery; Model B: Facilities where women receive only first dose of ART at ANC, and are referred to the ART clinic for
follow-up; Model C: Facilities where women are referred from ANC to the ART clinic for initiation and follow-up of ART; Model D: Facilities serving as ART referral sites (not providing ANC).
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8
first three months on ART and in particular before the first
follow-up visit [5].
The difference that we found in six-month retentions
between districts could be explained by variation in district
health management capacity, a different level of non-
governmental organization support, or ethnic and cultural
differences that may influence ART uptake and compliance.
Our finding that low retention rates are associated with
larger patient volumes at health facilities confirms earlier
observations [5], and may be related to less favourable
health-system factors in larger ART programs, such as patient
burden per staff member and longer waiting times.
Several limitations of our study need to be considered. We
studied a large sample of Malawi health centres, but our
results may not be representative for health facilities outside
the South East Zone. We were not able to analyse variables
at individual patient level, which may have differed between
health facilities and across models of PMTCT care. Although
we used multivariable analysis to study the association of
models of PMTCT care with retention on ART, health facilities
are likely to have made decisions about the organization of
PMTCT care on the basis of factors related to their specific
circumstances leaving a potential for residual confounding.
We did not study attrition that may have occurred during
linkage of care before the start of ART, which is particularly
applicable to Models C and D, and may have resulted in
selection bias.
Conclusions
A large variety exists in the way health facilities have
integrated PMTCT Option B care into the routine service
delivery. This study shows that the ‘‘model of care’’ that
health facilities chose to achieve this integration is associated
with uptake of HTC in ANC and retention in care on ART.
Further patient-level research is needed to ascertain whether
time between HIV diagnosis and ART initiation affect
retention in care and to determine which specific service
delivery models are most successful in promoting initiation of
ART and achieving adherence to lifelong treatment.
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